Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: December 14, 2011

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Complera	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Brilinta	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required
Edarbi	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Daliresp	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Pradaxa	New Drug Appeal	Require Prior Approval	Prior Approval Required
Incivek	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Latuda	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Exelon Patch	PDL Appeal	Remove Prior Approval Requirement	Prior Approval Required

Footer